ASH 2019 Myeloma Highlights: Genetic Engineering of T-cells, Dara-VMP for Transplant-ineligible Pts, D-RVd as a Potential SOC for Transplant-eligible Pts & Prognostic Value of PET-CT
Comments 0
Login to view comments.
Click here to Login
